Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

LifeStance Health (LFST) Accumulated Expenses: 2021-2024

Historic Accumulated Expenses for LifeStance Health (LFST) over the last 4 years, with FY2024 value amounting to $117.5 million.

  • LifeStance Health's Accumulated Expenses rose 171.11% to $113.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $113.8 million, marking a year-over-year increase of 171.11%. This contributed to the annual value of $117.5 million for FY2024, which is 1462.07% up from last year.
  • Latest data reveals that LifeStance Health reported Accumulated Expenses of $117.5 million as of FY2024, which was up 1462.07% from $102.5 million recorded in FY2023.
  • LifeStance Health's Accumulated Expenses' 5-year high stood at $117.5 million during FY2024, with a 5-year trough of $60.0 million in FY2021.
  • Moreover, its 4-year median value for Accumulated Expenses was $89.1 million (2022), whereas its average is $88.9 million.
  • Per our database at Business Quant, LifeStance Health's Accumulated Expenses surged by 3546.33% in 2023 and then surged by 1462.07% in 2024.
  • Annual analysis of 4 years shows LifeStance Health's Accumulated Expenses stood at $60.0 million in 2021, then grew by 26.08% to $75.6 million in 2022, then soared by 35.46% to $102.5 million in 2023, then rose by 14.62% to $117.5 million in 2024.
  • Its Accumulated Expenses stands at $117.5 million for FY2024, versus $102.5 million for FY2023 and $75.6 million for FY2022.